Evaluating Thrombocytopenia During Heparin Therapy

JAMA. 2018 Feb 6;319(5):497-498. doi: 10.1001/jama.2017.21898.

Authors

Yu-Min Shen^{1

2}, Heather Wolfe¹, Stephen Barman³

Affiliations

¹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
² Divisions of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas.
³ Divisions of Hematology and Oncology, Washington University School of Medicine, St Louis, Missouri.

PMID: 29411014
DOI: 10.1001/jama.2017.21898

No abstract available

MeSH terms

Anticoagulants / adverse effects*
Anticoagulants / therapeutic use
Heparin / adverse effects*
Humans
Intestine, Small / blood supply
Intestine, Small / surgery*
Ischemia / surgery
Male
Mesenteric Artery, Superior
Mesenteric Vascular Occlusion / surgery
Middle Aged
Thrombocytopenia / chemically induced*
Venous Thrombosis / surgery*

Substances

Anticoagulants
Heparin